BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9039176)

  • 1. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
    Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
    Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research.
    Smith KJ; Konzelman JL; Lombardo FA; Skelton HG; Holland TT; Yeager J; Wagner KF; Oster CN; Chung R
    Arch Dermatol; 1992 Oct; 128(10):1365-70. PubMed ID: 1417025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
    Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
    J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
    Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
    Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
    Friedman M; Venkatesan TK; Caldarelli DD
    Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A juvenile case of classic Kaposi's sarcoma.
    Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S
    Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
    Epstein JB
    Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Kaposi's sarcoma with vinblastine.
    Klein E; Schwartz RA; Laor Y; Milgrom H; Burgess GH; Holtermann OA
    Cancer; 1980 Feb; 45(3):427-31. PubMed ID: 7353196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.
    Turk HM; Buyukberber S; Camci C; Inaloz HS; Sari I; Kirtak N; Uner A
    J Dermatol; 2002 Oct; 29(10):657-60. PubMed ID: 12432999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
    Moyle G; Youle M; Barton S
    Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
    Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
    Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma.
    Brambilla L; Miedico A; Ferrucci S; Romanelli A; Brambati M; Vinci M; Tedeschi L; Boneschi V
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1090-4. PubMed ID: 16987264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the treatment of Kaposi's sarcoma with vinblastine in Togo: a study of 23 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Balaka A; Pitché P; Tchangaï-Walla K
    Bull Soc Pathol Exot; 2011 Dec; 104(5):339-41. PubMed ID: 21359830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment modalities for intraoral Kaposi's sarcoma: report of case.
    Chockley B; Coke JM
    Spec Care Dentist; 1991; 11(6):231-3. PubMed ID: 1839938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.